-
NIAID Research Education Program Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed)
(PAR-23-282)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): Multiple dates, see announcement.
-
Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
(PAR-23-293)
National Human Genome Research Institute
National Institute of Allergy and Infectious Diseases
National Cancer Institute
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Environmental Health Sciences
National Eye Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Office of Research on Women's Health
Office of Behavioral and Social Sciences Research
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): Multiple dates, see announcement.
-
Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
(PAR-23-294)
National Human Genome Research Institute
National Institute of Allergy and Infectious Diseases
National Cancer Institute
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Environmental Health Sciences
National Eye Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
John E. Fogarty International Center
Office of Research on Women's Health
Office of Behavioral and Social Sciences Research
Application Receipt Date(s): November 18, 2026
-
Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
(PAR-23-295)
National Human Genome Research Institute
National Institute of Allergy and Infectious Diseases
National Cancer Institute
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Environmental Health Sciences
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health
John E. Fogarty International Center
Office of Research on Women's Health
Office of Behavioral and Social Sciences Research
Application Receipt Date(s): November 16, 2026
-
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
(PAR-23-313)
National Cancer Institute
Application Receipt Date(s): October 14, 2026
-
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)
(PAR-23-314)
National Cancer Institute
Application Receipt Date(s): October 14, 2026
-
Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed)
(PAR-24-039)
National Cancer Institute
Application Receipt Date(s): November 17, 2026
-
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
(PAR-24-043)
National Institute of Neurological Disorders and Stroke
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Eye Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health
National Center for Complementary and Integrative Health
Office of Behavioral and Social Sciences Research
Application Receipt Date(s): August 18, 2026
-
NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)
(PAR-24-049)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): Multiple dates, see announcement.
-
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
(PAR-24-063)
National Institute of Neurological Disorders and Stroke
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Eye Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health
National Center for Complementary and Integrative Health
Office of Behavioral and Social Sciences Research
Application Receipt Date(s): August 18, 2026
-
Single Source: AIDS and Cancer Specimen Resource (ACSR; UM1 Clinical Trials Not Allowed)
(RFA-CA-23-043)
National Cancer Institute
Application Receipt Date(s): January 9, 2024
-
Effect of HIV and Substance Use Comorbidity on the Placenta and Maternal Outcomes (R01 Clinical Trial Optional)
(RFA-DA-25-021)
National Institute on Drug Abuse
Application Receipt Date(s): Not Applicable
-
Advancing Technologies to Improve Delivery of Pharmacological, Gene Editing, and other Cargoes for HIV and SUD Mechanistic or Therapeutic Research (R01 Clinical Trial Optional)
(RFA-DA-25-022)
National Institute on Drug Abuse
Application Receipt Date(s): November 15, 2024
-
Psychedelics Treatment Research in Substance Use Disorder (UG3/UH3 Clinical Trials Optional)
(RFA-DA-25-058)
National Institute on Drug Abuse
Application Receipt Date(s): February 28, 2024
-
Development of Novel Nonsteroidal Contraceptive Methods (R61/R33 - Clinical Trial Not Allowed)
(RFA-HD-25-008)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): March 29, 2024
-
Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R01 Clinical Trial Optional)
(RFA-MH-24-180)
National Institute of Mental Health
Application Receipt Date(s): March 1, 2024
-
Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R21 Clinical Trial Optional)
(RFA-MH-24-181)
National Institute of Mental Health
Application Receipt Date(s): March 1, 2024
-
Short Courses in Social Determinants of Health for Research Education in Nursing Research (R25 Independent Clinical Trial Not Allowed)
(RFA-NR-24-002)
National Institute of Nursing Research
Application Receipt Date(s): July 1, 2024
-
HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)
(RFA-NS-24-019)
National Institute of Neurological Disorders and Stroke
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Cancer Institute
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Eye Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Heart, Lung, and Blood Institute
National Center for Complementary and Integrative Health
Application Receipt Date(s): January 7, 2027
-
BRAIN Initiative Connectivity across Scales Data Coordinating Center (BRAIN CONNECTS DCC) (U24 Clinical Trial Not Allowed)
(RFA-NS-24-028)
National Institute of Neurological Disorders and Stroke
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Eye Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health
National Center for Complementary and Integrative Health
National Institute of Biomedical Imaging and Bioengineering
Application Receipt Date(s): January 29, 2024
-
IND-enabling Studies for Platform Clinical Trials of Genome Editing in Multiple Diseases (U01 Clinical Trial Not Allowed)
(RFA-RM-24-001)
Office of Strategic Coordination (Common Fund)
Application Receipt Date(s): February 22, 2024